Lord Hemphill is a director of Waverton Investment Management Limited. He has worked in the investment management business for over 35 years, having been a director at Morgan Grenfell, Deutsche Asset Management and Spencer House Capital Management. He is currently a member of the Legal Education Foundation’s investment committee, and a trustee of the Dulverton Trust and Highclere Castle. He became Chairman of UCLH Charity in October 2020.
Dr Junaid Bajwa was born at UCLH and is a practising GP with experience of serving a deprived London community. He is a non-executive director at UCLH. He has been interested in the use of technology and data to improve patient outcomes for many years, and has worked with NHS England on projects involving AI and data analytics. Over the past decade, he has also consulted for health care systems across the US, Australia, New Zealand, Singapore, and Europe, in addition to being seconded by the NHS to work with IBM. Academically, he completed his MBA at Imperial College London, is a Visiting Scientist at the Harvard School of Public Health (USA), and a Clinical Associate Professor at UCL (UK).
Nigel is a non-executive Director of Syncona Ltd and Chairman of Syncona Investment Management Limited. He is also Chairman of Oxford University Innovation, the technology transfer group for Oxford University, Chairman of the Oxford Academic Health Science Network, an entity established by the NHS England to align the interests of patients in its region with academia, industry and the healthcare system, and Chairman of Deltex Medical plc, an AIM listed medical device company. He was Chairman of Laird plc for 14 years and Oxford Instruments plc for 16 years. He has a degree in engineering from Cambridge University and is a Fellow of the Institute of Chartered Accountants and of the Institute of Engineering and Technology.
Adrian Parkhouse is a partner at the law firm, Farrer & Co LLP, where he qualified in 1984. A commercial litigator, he has particular experience in the conduct of disputes related to art. He has chaired the IBA’s Art Heritage and Law Committee and served on the International Council of Museums Legal Committee. He now sits on the Ethics Committee of the Museums Association. Adrian is a member of the charity’s property sub-committee.
Donald was appointed as Professor of Maternal Fetal Medicine at UCL in 2008. He is currently Clinical Director of Women’s Health at UCLH and Co-Clinical Director of the London Maternity Network. He has a number of research interests that focus on improving the outcomes for women and their babies following complicated pregnancies. His main grant funding relates to developing novel methods of fetal therapy including gene therapy for fetal growth restriction. He is also a sub-specialty accredited Consultant in Maternal Fetal Medicine at UCLH with a particular interest in fetal medicine. He is President of the Blair Bell Research Society and also a member of the RCOG’s Academic Committee.
James Petit joined the board of trustees in June 2021. He has over 30 years of experience in property investment and development. He was Head of UK Real Estate at Deutsche Asset Management, and managed diverse multinational teams and clients. He is a member of property committee overseeing all property matters within the Diocese of Westminster.
Mervyn Singer MB BS MD FRCP(Lon) FRCP(Edin) FFICM is Professor of Intensive Care Medicine at UCL and an NIHR Senior Investigator. His research, funded by the MRC, Wellcome Trust, NIHR and EU among others, focuses on sepsis, multi-organ failure, and innovative monitors, diagnostics and drugs. A monitor he developed is now in use in 30 countries worldwide and another is shortly to enter clinical trials. He co-chaired the Sepsis Redefinitions International Task Force whose recommendations (Singer et al, JAMA 2016) was the 19th most discussed research article worldwide (of 2.7 million) in 2016. He has written/edited multiple textbooks (including the Oxford Textbook of Critical Care) and peer-reviewed publications in major journals such as NEJM, Lancet, JAMA, BMJ and PLoSMed.